The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular tumor profiling and therapy selection in advanced gynecological cancers: A retrospective cohort analysis from the Australian Molecular Screening and Therapeutics (MoST) Program.
 
Damien Kee
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; MSD; Novartis
 
Frank Po-Yen Lin
No Relationships to Disclose
 
Subotheni Thavaneswaran
Research Funding - AstraZeneca (Inst); Elevation Oncology (Inst); Roche/Genentech (Inst)
 
Christine E Napier
No Relationships to Disclose
 
Michelle L. Harrison
Stock and Other Ownership Interests - CSL Limited (I)
Consulting or Advisory Role - Eisai (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
 
Philip James Beale
Honoraria - AstraZeneca; GlaxoSmithKline; GlaxoSmithKline
 
Jodi Lynch
No Relationships to Disclose
 
Alison J. Davis
No Relationships to Disclose
 
Sumitra Ananda
No Relationships to Disclose
 
Janine Margaret Lombard
Honoraria - AstraZeneca; GlaxoSmithKline; Novartis
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Lilly
 
Michael Friedlander
Honoraria - AstraZeneca; GlaxoSmithKline; MSD; Novartis
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; GlaxoSmithKline; Incyclix Bio; Lilly; MSD; Novartis; Takeda
Speakers' Bureau - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Novartis (Inst)
 
Maya Kansara
No Relationships to Disclose
 
Lucille Sebastian
Research Funding - AstraZeneca/MedImmune (Inst); Merck KGaA (Inst); Roche (Inst)
 
Chee Khoon Lee
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; Janssen Oncology; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Merck; Merck KGaA; Novartis; Pfizer; Takeda
Research Funding - Amgen; AstraZeneca (Inst); Merck KGaA (Inst); Roche (Inst)
 
Mandy L. Ballinger
Honoraria - Roche (I)
Research Funding - Amgen (I); AstraZeneca (I); Bayer (I); Elevation Oncology (I); George Clincal (I); Lilly (I); Microba (I); Pfizer (I); Roche (I); Seagen (I); Sun Pharma (I)
Travel, Accommodations, Expenses - Amgen (I)
 
John Simes
Consulting or Advisory Role - FivePhusion (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
David Morgan Thomas
Employment - Australian Unity
Honoraria - Roche
Research Funding - Amgen; AstraZeneca; Bayer; Elevation Oncology; George Clincal (Inst); InterVenn Biosciences; Lilly (Inst); Microba (Inst); Pfizer; Roche; Seagen (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Amgen